Study on Preparation of Chitosan Microspheres Loaded with Levofloxacin

Abstract:

Chitosan (CS) microspheres loaded with levofloxacin (LOF) were prepared by emulsion crosslinking technique and the experimental parameters were optimized by orthogonal tests. The influences of various factors on the combination properties of chitosan microspheres were discussed. The optimal preparation condition was 98000 chitosan molecular weight, 30mg/ml chitosan concentration, 5:1 volume ratio of oil to water, 1:1 molar ratio of amino group of chitosan to aldehyde group of glutaraldehyde (GA), 1500 rpm stirring rate, 2:1 mass ratio of chitosan to levofloxacin and 1 h crosslinking time. The CS microspheres prepared under optimal parameters had spherical morphology with 1.59 μm of average geometric diameter and 0.99 of span, its loading capacity (LC) and association efficiency (AE) values were 21.71% and 80.49% respectively. In vitro release profile showed the levofloxacin released fast initially, and then slowly from the microspheres with T₉₀ occurring at 188.5h and its delivery behavior conformed to First-Order release kinetics model.

• Periodical: Key Engineering Materials (Volumes 609-610)
• Pages: 442-448
• DOI: https://doi.org/10.4028/www.scientific.net/KEM.609-610.442
• Online since: April 2014
• Authors: Jing Guan*, Peng Cheng, Shu Jie Huang, Zhi Hong Li, Xi Zheng Zhang, Ji Min Wu, Yong Guo, Rui Xin Li
• Keywords: Chitosan, Emulsion Crosslinking, Levofloxacin, Microsphere, Preparation

References

[1] Y. Kohlhammer, H. Raspe, R. Marre, N. Suttorp, T. Welte, and T. Schafer, Antibiotic treatment of community acquired pneumonia varies widely across Germany, J. Infect. 54 (2007) 446-453.

DOI: 10.1016/j.jinf.2006.08.010

[2] T.P. Learoyd, J.L. Burrows, E. French, and P.C. Seville, Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate, Eur. J. Pharm. Biopharm. 68 (2008) 224-234.

DOI: 10.1016/j.ejpb.2007.04.017

[3] C. Bosquillon, C. Lombry, V. Preat, and R. Vanbever, Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance, J. Control. Release 70 (2001) 329-339.

DOI: 10.1016/s0168-3659(00)00362-x

[4] H.M. Courrier, N. Butz, and T.F. Vandamme, Pulmonary drug delivery system: recent developments and prospects, Crit. Rev. Ther. Drug Carr. Syst. 19 (2002) 425-498.

DOI: 10.1615/critrevtherdrugcarriersyst.v19.i45.40

[5] S. Giovagnoli, P. Blasi, A. Schoubben, C. Rossi, and M. Ricci, Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery, Int. J. Pharm. 333 (2007) 103-111.

DOI: 10.1016/j.ijpharm.2006.10.005

[6] C.A. Ventura, S. Tommasini, E. Crupi, I. Giannone, V. Cardile, T. Musumeci, and G. Puglisi, Chitosan microspheres for intrapulmonary administration of moxifloxacin: Interaction with biomembrane models and in vitro permeation studies, Eur. J. Pharm. Biopharm. 68 (2008).

DOI: 10.1016/j.ejpb.2007.05.011

[7] K. Ohashi, T. Kabasawa, T. Ozeki, and H. Okada, One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis, J. Control. Release 135 (2009).

DOI: 10.1016/j.jconrel.2008.11.027

[8] S.M. Wimer, L. Schoonover and M.W. Garrison, Levofloxacin: A therapeutic review, Clin. Ther. 20 (1998) 1049-1070.

DOI: 10.1016/s0149-2918(98)80104-5

[9] J. Du, R. Sun, S. Zhang, T. Govender, L.F. Zhang, C.D. Xiong, and Y.X. Peng, Novel polyelectrolyte carboxymethyl konjac glucomannan–chitosan nanoparticles for drug delivery, Macromol. Rapid Commun. 25 (2004) 954-958.

DOI: 10.1002/marc.200300314

[10] C. Muzzarelli, V. Stanic, L. Gobbi, G. Tosi, and R. Muzzarelli, Spray-drying of solutions containing chitosan together with polyuronans and characterisation of the microspheres, Carbohydr. Polym. 57 (2004) 73-82.

DOI: 10.1016/j.carbpol.2004.04.002

[11] S.A. Agnihotri, and T.M. Aminabhavi, Controlled release of clozapine through chitosan microparticles prepared by a novel method, J. Controlled Release 96 (2004) 245-259.

DOI: 10.1016/j.jconrel.2004.01.025

[12] S.W. Ali, M. Joshi, and S. Rajendran, Modulation of size, shape and surface charge of chitosan nanoparticles with reference to antimicrobial activity, Adv. Sci. Lett. 3 (2010) 452-460.

DOI: 10.1166/asl.2010.1152

[13] A.K. Anal, W.F. Stevens, and C. Remunan-Lopez, Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin, Int. J. Pharm. 312 (2006) 166-173.

DOI: 10.1016/j.ijpharm.2006.01.043

[14] K.C. Gupta, and F.H. Jabrail, Glutaraldehyde and glyoxal cross-linked chitosan microspheres for controlled delivery of centchroman, Carbohydr. Res. 341 (2006) 744-756.

DOI: 10.1016/j.carres.2006.02.003

[15] S.A. Agnihotri, N.N. Mallikarjuna, and T.M. Aminabhavi, Advances on chitosan-based micro- and nanoparticles in drug delivery, J. Controlled Release 100 (2004) 5-28.

DOI: 10.1016/j.jconrel.2004.08.010

[16] A.A.K. Ahmed, H.S.B. Naik, and B.S. Sherigara. Synthesis and characterization of chitosan-based pH-sensitive semi-interpenetrating network microspheres for controlled release of diclofenac sodium, Carbohydr. Res. 344 (2009) 699-706.

DOI: 10.1016/j.carres.2009.01.011

[17] J.Q. Qian, and Y.Z. Ma, Preparation of levofloxacin-chitosan sustained release microsphere. J. Zhejiang Univ. Tech. 32 (2004) 20-24.

[18] H.L. Shen, Q. Wang, F. Qian, A.L. Liu, and Y. Li, Preparation and in vitro release of levofloxacin carboxymethyl ehitosan sustained—releasing microsphere, Acad. J. Sec. Mil. Med. Univ. 25 (2004) 482-484.

[19] S. Papadimitriou, D. Bikiaris, K. Avgoustakis, E. Karavas, and M. Georgarakis, Chitosan nanoparticles loaded with dorzolamide and pramipexole, Cabohydr. Polym. 73 (2008) 44-54.

DOI: 10.1016/j.carbpol.2007.11.007